logo

For the Inventor, By the Inventor

Watchung, NJ, United States of America

Max Wilhelm

USPTO Granted Patents = 9

Average Co-Inventor Count = 1.7

ph-index = 4

Forward Citations = 32(Granted Patents)


Company Filing History:

goldMedal9 out of 6,850 
 
Ciba-geigy Corporation
 patents

Years Active: 1976-1984

Loading Chart...
9 patents (USPTO):Explore Patents
1. 4479967 - Method of lowering intraocular pressure with ibuterol (1984-10-30),
2. 4120978 - Pharmaceutical composition for inhibiting and blocking cardioselective (1978-10-17),
3. 4075335 - Pharmaceutical piperidine derivatives (1978-02-21),
4. 4075208 - 1-Substituted-4-(2-oxo-hexahydro-1-pyrimidinyl)-piperidine (1978-02-21),
5. 4045580 - Pharmaceutical preparation using (1977-08-30),
6. 4038313 - Cycloalkylureido phenoxy propanolamines (1977-07-26),
7. 4017542 - 9-(2-Hydroxy-3-amino-propyl)-9,10-dihydro-9,10-ethano-anthracenes and (1977-04-12),
8. 3956335 - 1-Substituted-4-(2-oxo-1-imidazolidinyl) piperidines (1976-05-11),
9. 3935259 - New amines and processes for their manufacture (1976-01-27),

Title: Max Wilhelm: Innovator in Ophthalmic and Cardiac Pharmaceutical Solutions

Introduction

Max Wilhelm is a notable inventor based in Watchung, NJ (US), recognized for his contributions to the fields of ophthalmology and cardiology. With a total of 9 patents, Wilhelm has made significant strides in developing innovative methods and pharmaceutical compositions that address critical health issues.

Latest Patents

One of Wilhelm's latest patents is a method of lowering intraocular pressure with ibuterol. This invention relates to a method of lowering intraocular pressure through the topical application of 2-tert-butylamino-1-(3,5-diisobutyryloxyphenyl)-ethanol or its acid addition salt onto the eye of a mammalian species, including humans. This method serves as a conservative and/or curative medical treatment for ocular hypertension and related pathological states, particularly in first-line glaucoma cases. Additionally, he has developed a pharmaceutical composition for inhibiting and blocking cardioselective agents. This composition includes compounds that are effective in inhibiting cardiac beta-receptors, showcasing his versatility in addressing both ocular and cardiac health.

Career Highlights

Max Wilhelm has built a distinguished career at Ciba-Geigy Corporation, where he has been instrumental in advancing pharmaceutical research and development. His work has not only contributed to the company's portfolio but has also had a lasting impact on medical treatments available today.

Collaborations

Throughout his career, Wilhelm has collaborated with esteemed colleagues such as Kurt Eichenberger and Herbert Schroter. These partnerships have fostered innovation and have been pivotal in the successful development of his patented technologies.

Conclusion

Max Wilhelm's innovative contributions to ophthalmic and cardiac pharmaceuticals underscore his role as a leading inventor in the medical field. His patents reflect a commitment to improving patient care through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…